Tikva Allocell
Business Services · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
61 Biopolis Dr Proteos, Singapore, Centr...Website
www.tikvaallocell.comRevenue
<$5 MillionIndustry
About Tikva Allocell
Tikva Allocell Org Chart
Is Tikva Allocell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Tikva Allocell is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Tikva Allocell launches new products
Earning: See what the market has to say on Tikva Allocell recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Tikva Allocell
Check if Tikva Allocell has recently received funding, and reach out quickly before it becomes old news!
Click to see if Tikva Allocell had a recent Job posting/layoffs
Tikva Allocell, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Tikva Allocell has new funding data
Recommended Actions
Reach out to Masked Content who joined Tikva Allocell as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Tikva Allocell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tikva Allocell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tikva Allocell.
Tikva Allocell financials insights
Gather financial insights about Tikva Allocell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$8M
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tikva Allocell
Tikva Allocell is a Singapore-based preclinical biotechnology company developing next-generation, off-the-shelf T cell therapies for difficult-to-treat cancers and autoimmune diseases. Leveraging its proprietary Allogeneic EBV-Specific T Cell (ALLO EBVST) platform and innovative cell engineering technologies, the company is focused on creating safe... Read More
